EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma

Colin H Quinn, Janet R Julson, Hooper R Markert, Nazia Nazam, Swatika Butey, Jerry E Stewart, Jennifer C Coleman, James M Markert, Jianmei W Leavenworth, Elizabeth A Beierle

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03818-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Colin H Quinn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, 1600 7th Ave. South, Lowder, Room 300, Birmingham, AL, 352…. Hauptthemen laut MEDLINE: Neuroblastoma, Killer Cells, Natural, Oncolytic Virotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neuroblastoma is the most common extracranial solid tumor in children and accounts for 15% of pediatric cancer related deaths. Targeting neuroblastoma with immunotherapies has proven challenging due to a paucity of immune cells in the tumor microenvironment and the release of immunosuppressive cytokines by neuroblastoma tumor cells. We hypothesized that combining an oncolytic Herpes Simplex Virus (oHSV) with natural killer (NK) cells might overcome these barriers and incite tumor cell death. METHODS: We utilized MYCN amplified and non-amplified neuroblastoma cell lines, the IL-12 expressing oHSV, M002, and the human NK cell line, NK-92 MI. We assessed the cytotoxicity of NK cells against neuroblastoma with and without M002 infection, the effects of M002 on NK cell priming, and the impact of M002 and priming on the migratory capacity and CD107a expression of NK cells. To test clinical applicability, we then investigated the effects of M002 and NK cells on neuroblastoma in vivo. RESULTS: NK cells were more attracted to neuroblastoma cells that were infected with M002. There was an increase in neuroblastoma cell death with the combination treatment of M002 and NK cells both in vitro and in vivo. Priming the NK cells enhanced their cytotoxicity, migratory capacity and CD107a expression. CONCLUSIONS: To the best of our knowledge, these investigations are the first to demonstrate the effects of an oncolytic virus combined with self-maintaining NK cells in neuroblastoma and the priming effect of neuroblastoma on NK cells. The current studies provide a deeper understanding of the relation between NK cells and neuroblastoma and these data suggest that oHSV increases NK cell cytotoxicity towards neuroblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaKiller Cells, NaturalOncolytic VirotherapyHumansAnimalsMiceCell Line, TumorOncolytic VirusesCytotoxicity, ImmunologicSimplexvirusXenograft Model Antitumor Assays

Stichwörter der Autor:innen

ImmunotherapyNatural killer cellsNeuroblastomaOncolytic virusTranslational research

Autor:innen und Institutionen

  • Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, 1600 7th Ave. South, Lowder, Room 300, Birmingham, AL, 35233, UK.
  • Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
  • Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, 1600 7th Ave. South, Lowder, Room 300, Birmingham, AL, 35233, UK. elizabeth.beierle@childrensal.org.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institutes of Health,United States
  • Kaul Pediatric Research Institute,United States
  • Rally Foundation for Childhood Cancer Research
  • Hyundai Hope On Wheels,United States

Zitieren

APA

Quinn, C. H., Julson, J. R., Markert, H. R., Nazam, N., Butey, S., Stewart, J. E., Coleman, J. C., Markert, J. M., Leavenworth, J. W., & Beierle, E. A. (2024). Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03818-y

Vancouver

Quinn CH, Julson JR, Markert HR, Nazam N, Butey S, Stewart JE, et al. Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03818-y

BibTeX
@article{Quinn2024,
  author = {Quinn, Colin H and Julson, Janet R and Markert, Hooper R and Nazam, Nazia and Butey, Swatika and Stewart, Jerry E and Coleman, Jennifer C and Markert, James M and Leavenworth, Jianmei W and Beierle, Elizabeth A},
  title = {Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03818-y}
}
Kostenlos starten →